Literature DB >> 9661653

Compound heterozygous deletion of the PROP-1 gene in children with combined pituitary hormone deficiency.

O Fofanova1, N Takamura, E Kinoshita, J S Parks, M R Brown, V A Peterkova, O V Evgrafov, N P Goncharov, A A Bulatov, I I Dedov, S Yamashita.   

Abstract

Mutations in the prophet of Pit-1 gene (PROP1) have been shown to be responsible for combined pituitary hormone deficiency (CPHD) with deficiencies of growth hormone (GH), Prolactin (Prl), thyroid-stimulating hormone (TSH) and gonadotropins. We previously reported that homozygosity for a 2bp deletion in exon 2 (296delGA) accounted for CPHD in three patients from two Russian families. Here we report a second mutational hot spot in exon 2. This 2bp 149delGA deletion results in a frame shift that leads to the same serine to stop codon change at codon 109 (S109X). The predicted proteins are each truncated at residue 108 but diverge from the wild type sequence at different points in the homeodomain. Compound heterozygosity for the two mutations (149delGA/296delGA) was detected in 5 of 14 CPHD children from 4 families (36%). This provides the first evidence of heterozygosity for two common deletions as a cause of CPHD in Russian children.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9661653     DOI: 10.1210/jcem.83.7.5094

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  15 in total

1.  Cloning, expression and genomic structure of a novel human GNB2L1 gene, which encodes a receptor of activated protein kinase C (RACK).

Authors:  Shu Wang; Jin-Zhong Chen; Zhen Zhang; Shaohua Gu; Chaoneng Ji; Rong Tang; Kang Ying; Yi Xie; Yumin Mao
Journal:  Mol Biol Rep       Date:  2003-03       Impact factor: 2.316

Review 2.  Other transcription factors and hypopituitarism.

Authors:  Laurie E Cohen; Sally Radovick
Journal:  Rev Endocr Metab Disord       Date:  2002-12       Impact factor: 6.514

Review 3.  Molecular determinants of pituitary cytodifferentiation.

Authors:  S L Asa; S Ezzat
Journal:  Pituitary       Date:  1999-05       Impact factor: 4.107

Review 4.  Human gene mutations causing infertility.

Authors:  L C Layman
Journal:  J Med Genet       Date:  2002-03       Impact factor: 6.318

5.  Adrenocorticotrope deficiency with clinical evidence for late onset in combined pituitary hormone deficiency caused by a homozygous 301-302delAG mutation of the PROP1 gene.

Authors:  C Lamesch; S Neumann; R Pfäffle; W Kiess; R Paschke
Journal:  Pituitary       Date:  2002       Impact factor: 4.107

Review 6.  Combined pituitary hormone deficiency: current and future status.

Authors:  F Castinetti; R Reynaud; M-H Quentien; N Jullien; E Marquant; C Rochette; J-P Herman; A Saveanu; A Barlier; A Enjalbert; T Brue
Journal:  J Endocrinol Invest       Date:  2014-09-09       Impact factor: 4.256

7.  A unique case of combined pituitary hormone deficiency caused by a PROP1 gene mutation (R120C) associated with normal height and absent puberty.

Authors:  Armando Arroyo; Flavia Pernasetti; Vyacheslav V Vasilyev; Paula Amato; Samuel S C Yen; Pamela L Mellon
Journal:  Clin Endocrinol (Oxf)       Date:  2002-08       Impact factor: 3.478

Review 8.  Genetic regulation of the embryology of the pituitary gland and somatotrophs.

Authors:  L E Cohen
Journal:  Endocrine       Date:  2000-04       Impact factor: 3.925

Review 9.  Genetic regulation of pituitary gland development in human and mouse.

Authors:  Daniel Kelberman; Karine Rizzoti; Robin Lovell-Badge; Iain C A F Robinson; Mehul T Dattani
Journal:  Endocr Rev       Date:  2009-10-16       Impact factor: 19.871

10.  High prevalence of PROP1 gene mutations in Hungarian patients with childhood-onset combined anterior pituitary hormone deficiency.

Authors:  Zita Halász; Judit Toke; Attila Patócs; Rita Bertalan; Zsófia Tömböl; Agnes Sallai; Eva Hosszú; Agota Muzsnai; László Kovács; János Sólyom; György Fekete; Károly Rácz
Journal:  Endocrine       Date:  2006-12       Impact factor: 3.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.